DEPP1 and neuroblastoma: As FOXO3 controls cellular ROS steady-state levels via DEPP expression [9], the present study was designed to investigate the impact of FOXO3 and DEPP on autophagy and associated effects on ROS-mediated cell death as well as therapy resistance in human neuroblastoma.